Vision-related quality of life after transsphenoidal surgery for pituitary adenoma

Investigative Ophthalmology and Visual Science

Volumn 51, Issue 7, 2010, Pages 3405-3410

  Okamoto, Yoshifumi ^a   Okamoto, Fumiki ^a   Yamada, Shozo ^b   Honda, Maiko ^b   Hiraoka, Takahiro ^a   Oshika, Tetsuro ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b TORANOMON HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; COMORBIDITY; CRITICAL FLICKER FUSION; DISEASE DURATION; EYE DISEASE; FEMALE; GENDER; HUMAN; HYPOPHYSIS ADENOMA; MAJOR CLINICAL STUDY; MALE; NATIONAL EYE INSTITUTE VISUAL FUNCTION QUESTIONNAIRE; OUTCOME ASSESSMENT; PERIMETRY; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; QUALITY OF LIFE; QUANTITATIVE ANALYSIS; REGRESSION ANALYSIS; SCORING SYSTEM; TRANSSPHENOIDAL SURGERY; TUMOR VOLUME; VISION; VISUAL FIELD DEFECT; ADENOMA; EYE SURGERY; HYPOPHYSIS TUMOR; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; SICKNESS IMPACT PROFILE; SPHENOID; VISUAL ACUITY; VISUAL DISORDER;

ADENOMA; ADULT; AGED; FEMALE; FLICKER FUSION; HUMANS; MALE; MIDDLE AGED; OPHTHALMOLOGIC SURGICAL PROCEDURES; PITUITARY NEOPLASMS; QUALITY OF LIFE; REGRESSION ANALYSIS; SICKNESS IMPACT PROFILE; SPHENOID BONE; VISION DISORDERS; VISION, OCULAR; VISUAL ACUITY; YOUNG ADULT;

EID: 77955893269     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.09-3763     Document Type: Article

References (33)

1. Hollenhorst RW, Younge BR. Ocular manifestations produced by adenomas of the pituitary gland: analysis of 1000 cases. In: Kohler PO, Ross GT, eds. Diagnosis and Treatment of Pituitary Tumors. Amsterdam: Excerpta Medica; 1973:53-59.
2. Ebersold MJ, Quast LM, Laws ER Jr, Scheithauer B, Randall RV. Long-term results in transsphenoidal removal of nonfunctioning pituitary adenomas. J Neurosurg. 1986;64:713-719.
3. Anderson D, Faber P, Marcovitz S, Hardy J, Lorenzetti D. Pituitary tumors and the ophthalmologist. Ophthalmology. 1983;90:1265-1270.
4. Laws ER, Jane JA Jr. Neurosurgical approach to treating pituitary adenomas (review). Growth Horm IGF Res. 2005;15(suppl A): S36-S41.
5. Kayan A, Earl CJ. Compressive lesions of the optic nerves and chiasm: pattern of recovery of vision following surgical treatment. Brain. 1975;98:13-28.
6. Mangione CM, Lee PP, Gutierrez PR, Spritzer K, Berry S, Hays RD. Development of the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol. 2001;119:1050-1058.
7. Suzukamo Y, Oshika T, Yuzawa M, et al. Psychometric properties of the 25-item National Eye Institute Visual Function Questionnaire (NEI VFQ-25): Japanese version. Health Qual Life Outcomes. 2005; 3:65.
8. Ghazi-Nouri SM, Tranos PG, Rubin GS, Adams ZC, Charteris DG. Visual function and quality of life following vitrectomy and epireti-nal membrane peel surgery. Br J Ophthalmol. 2006;90:559-562.
9. Hyman LG, Komaroff E, Heijl A, Bengtsson B, Leske M. Treatment and vision-related quality of life in the early manifest glaucoma trial. Ophthalmology. 2005;112:1505-1513.
10. Cusick M, SanGiovanni JP, Chew EY, et al. Central visual function and the NEI VFQ-25 near and distance activities subscale scores in people with type 1 and 2 diabetes. Am J Ophthalmol. 2005;139: 1042-1050.
11. Berdeaux GH, Nordmann JP, Colin E, Arnould B. Vision-related quality of life in patients suffering from age-related macular degeneration. Am J Ophthalmol. 2005;139:271-279.
12. Cahill MT, Banks AD, Stinnett SS, Toth CA. Vision-related quality of life in patients with bilateral severe age-related macular degeneration. Ophthalmology. 2005;112:152-158.
13. Cahill MT, Stinnett SS, Banks AD, Freedman S, Toth C. Quality of life after macular translocation with 360° peripheral retinectomy for age-related macular degeneration. Ophthalmology. 2005;112: 144-151.
14. Tranos PG, Ghazi-Nouri SM, Rubin GS, Adams D, Charteris D. Visual function and subjective perception of visual ability after macular hole surgery. Am J Ophthalmol. 2004;138:995-1002.
15. Kymes SM, Walline JJ, Zadnik K, Gordon MO. Collaborative Longitudinal Evaluation of Keratoconus Study Group: quality of life in keratoconus. Am J Ophthalmol. 2004;138:527-535.
16. Johnson MD, Woodburn CJ, Vance ML. Quality of life in patients with a pituitary adenoma. Pituitary. 2003;6:81-87.
17. Lindsay JR, Nansel T, Baid S, Gumowski J, Nieman LK. Long-term impaired quality of life in Cushing's syndrome despite initial improvement after surgical remission. J Clin Endocrinol Metab. 2006;91:447-453.
18. Berglund G, Lidén A, Hansson MG, Öberg K, Sjöden PO, Nordin K. Quality of life in patients with multiple endocrine neoplasia type 1 (MEN1). Fam Cancer. 2003;2:27-33.
19. Powell M. Recovery of vision following transsphenoidal surgery for pituitary adenomas. Br J Neurosurg. 1995;9:367-373.
20. Katz J, Sommer A. Reliability indexes of automated perimetric tests. Arch Ophthalmol. 1988;106:1252-1254.
21. Cohen AR, Cooper PR, Kupersmith MJ, Flamm ES, Ransohoff J. Visual recovery after transsphenoidal removal of pituitary adenomas. Neurosurgery. 1985;17:446-452.
22. Peter M, De Tribolet N. Visual outcome after transsphenoidal surgery for pituitary adenomas. Br J Neurosurg. 1995;9:151-157.
23. Gnanalingham KK, Bhattacharjee S, Pennington R, Ng J, Mendoza N. The time course of visual field recovery following transsphe-noidal surgery for pituitary adenomas: predictive factors for a good outcome. J Neurol Neurosurg Psychiatry. 2005;76:415-419.
24. Hirneiss C, Neubauer AS, Gass CA, et al. Visual quality of life after macular hole surgery: outcome and predictive factors. Br J Oph-thalmol. 2007;91:481-484.
25. The Committee of Brain Tumor Registry of Japan. Report of Brain Tumor Registry of Japan (1969-1993). 10th ed. Tokyo Neurol Med Chir. 2000;40(suppl):1-106.
26. Biermasz NR, van Thiel SW, Pereira AM, et al. Decreased quality of life in patients with acromegaly despite long-term cure of growth hormone excess. J Clin Endocrinol Metab. 2004;89:5369-5376.
27. van Aken MO, Pereira AM, Biermasz NR, et al. Quality of life in patients after long-term biochemical cure of Cushing's disease. J Clin Endocrinol Metab. 2005;90:3279-3286.
28. Dekkers OM, van der Klaauw AA, Pereira AM, et al. Quality of life is decreased after treatment for nonfunctioning pituitary macroad-enoma. J Clin Endocrinol Metab. 2006;91:3364-3369.
29. Kauppinen-Mäkelin R, Sane T, Sintonen H, et al. Quality of life in treated patients with acromegaly. J Clin Endocrinol Metab. 2006; 91:3891-3896.
30. Rowles SV, Prieto L, Badia X, Shalet SM, Webb SM, Trainer PJ. Quality of life (QOL) in patients with acromegaly is severely impaired: use of a novel measure of QOL-acromegaly quality of life questionnaire. J Clin Endocrinol Metab. 2005;90:3337-3341.
31. Sonino N, Bonnini S, Fallo F, Boscaro M, Fava GA. Personality characteristics and quality of life in patients treated for Cushing's syndrome. Clin Endocrinol. 2006;64:314-318.
32. Okamoto Y, Okamoto F, Hiraoka T, Yamada S, Oshika T. Vision-related quality of life in patients with pituitary adenoma. Am J Ophthalmol. 2008;146:318-322.
33. Enger C, Sommer A. Recognizing glaucomatous field loss with the Humphrey STATPAC. Arch Ophthalmol. 1987;105:1355-1357.